Sanofi (SNY) Raw Materials (2015 - 2018)

Sanofi has disclosed Raw Materials across 4 years of filings, most recently posting $1.2 billion for Q4 2018.

• Raw Materials for Q4 2018 came in at $1.2 billion, up 2.38% year-over-year; the trailing twelve-month figure through Dec 2018 was $1.2 billion (up 2.38% YoY), and the FY2018 annual result was $1.2 billion, up 2.38% from the prior year.
• Raw Materials came in at $1.2 billion for Q4 2018 at Sanofi, up from $1.1 billion in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.2 billion in Q4 2018 to a low of $1.0 billion in Q4 2016.
• The 4-year median for Raw Materials is $1.1 billion (2015), against an average of $1.1 billion.
• Across the five-year window, Raw Materials dropped 2.62% in 2016 and advanced 10.54% in 2017, its largest moves.
• Sanofi's Raw Materials stood at $1.1 billion in 2015, then fell by 2.62% to $1.0 billion in 2016, then rose by 10.54% to $1.1 billion in 2017, then advanced by 2.38% to $1.2 billion in 2018.
• The last three Raw Materials figures came in at $1.2 billion (Q4 2018), $1.1 billion (Q4 2017), and $1.0 billion (Q4 2016), per Business Quant data.